Analyst Price Target is $0.00
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for Emerald Health Therapeutics in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $0.15.
Current Consensus is
The current consensus among 0 polled investment analysts is to n/a stock in Emerald Health Therapeutics. This rating has held steady since February 2020, when it changed from a Hold consensus rating.
Emerald Health Therapeutics, Inc., together with its subsidiaries, engages in the production and sale of medical cannabis for medical purpose in Canada. It offers dried cannabis strains, pre-rolls, ingestible extracts, and cannabis oil products to its medical patients. The company distributes its medical products through licensed wholesale pharmacies and to licensed wholesale clients. It also exports medical cannabis products to licensed wholesale purchasers in Europe. The company was formerly known as T-Bird Pharma Inc. and changed its name to Emerald Health Therapeutics, Inc. in June 2015. Emerald Health Therapeutics, Inc. is headquartered in Vancouver, Canada.